CHARM Therapeutics Inc. — Form D
CHARM Therapeutics Inc. of LONDON, X0, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-03. The offering totals $80.1M, of which $17.3M was reported sold. Industry: Other.
Offering
- Filed: 2025-09-03
- Form: D
- Accession: 0001231919-25-000181
- Industry: Other
- Exemptions: 06b
- Total offering: $80.1M
- Amount sold: $17.3M
- Remaining: $62.8M
- Investors: 20
- Date of first sale: 2025-08-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-556495
Issuer
- Name: CHARM Therapeutics Inc.
- CIK: 0001889676
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 7 PANCRAS SQUARE, LONDON, X0, N1C 4AG
- Phone: 447582703655
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Kim Blackwell | Director | Philadelphia, PA |
| Gary Glick | Director | LONDON, X0 |
| Rishi Gupta | Director | New York, NY |
| Mahesh Kudari | Director | LONDON, X0 |
| Matthew McAviney | Director | LONDON, X0 |
| Briggs Morrison | Director | Cambridge, MA |
| Nihal Sinha | Director | Encinitas, CA |
| Gary Glick | Executive Officer | LONDON, X0 |
| Gary Glick | Promoter | LONDON, X0 |
| Gary Singh Glick | Director | London, X0 |
| Lakshyaditya Singh Aithani | Director | London, X0 |
| Lakshyaditya Singh Aithani | Executive Officer | London, X0 |
| Lakshyaditya Singh Aithani | Promoter | London, X0 |
| Nihal Singh Sinha | Director | London, X0 |
| Muzammil Singh Mansuri | Director | London, X0 |
| Rishi Singh Gupta | Director | London, X0 |
Other filings by this issuer (3)
More